Nocardia Patents (Class 435/872)
  • Patent number: 4228239
    Abstract: A novel Antibiotic C-15003 P-3 is specifically produced by cultivating a microorganism of the genus Nocardia in a culture medium containing valine or isobutyric acid and/or their derivatives.The Antibiotic C-15003 P-3 is useful as an antifungal, antiprotozoan and antitumor agent.
    Type: Grant
    Filed: November 13, 1978
    Date of Patent: October 14, 1980
    Assignee: Takeda Chemical Industries, Ltd
    Inventors: Eiji Higashide, Kazunori Hatano, Mitsuko Asai
  • Patent number: 4225494
    Abstract: A novel Antibiotic C-15003 is produced by cultivating a microorganism of the genus Nocardia.The Antibiotic C-15003 is useful as an antifungal agent or an antiprotozoan agent.
    Type: Grant
    Filed: December 22, 1978
    Date of Patent: September 30, 1980
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Eiji Higashide, Mitsuko Asai, Seiichi Tanida
  • Patent number: 4212944
    Abstract: A new species of Nocardiopsis, designated Nocardiopsis atra Huang sp. nov. ATCC 31511, when aerobically propagated in an aqueous nutrient medium, produces nocardicin A in good yield.
    Type: Grant
    Filed: June 4, 1979
    Date of Patent: July 15, 1980
    Assignee: Pfizer Inc.
    Inventors: Walter D. Celmer, Liang H. Huang, Mark T. Jefferson, Hiroshi Maeda, Kozo Inoue, Riichiro Shibakawa
  • Patent number: 4212941
    Abstract: 9-(2-O-Acyl-.beta.-D-arabinofuranosyl)adenine compounds and their production by enzymatic removal of the 3-O-acyl and 5-O-acyl groups of a 9-(2,3-di-O-acyl-.beta.-D-arabinofuranosyl)adenine compound or a 9-(2,3,5-tri-O-acyl-.beta.-D-arabinofuranosyl)adenine compound. The monoester compounds are useful as antiviral agents. The compounds are water-soluble and lipophilic, thereby being adaptable to a wide variety of pharmaceutical formulations.
    Type: Grant
    Filed: May 23, 1977
    Date of Patent: July 15, 1980
    Assignee: Warner-Lambert Company
    Inventor: David C. Baker
  • Patent number: 4187292
    Abstract: The present invention relates to antibiotics C-14919 E-1 and E-2 produced by cultivating a microorganism of the genus Nocardia. These antibiotics display a wide activity against e.g. Gram-positive bacteria, fungi and yeast and are useful as germicides or disinfectants.
    Type: Grant
    Filed: July 12, 1977
    Date of Patent: February 5, 1980
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Eiji Higashide, Mitsuko Asai, Toru Hasegawa
  • Patent number: 4186251
    Abstract: The present invention relates to compositions and methods for use in determining free and total cholesterol levels in fluids such as body fluids. A test for free cholesterol is disclosed based on the determination of hydrogen peroxide released through the action of a chemical system having cholesterol oxidase activity on free cholesterol. A preferred means for determining the released hydrogen peroxide involves the use of a substance having peroxidative activity and an oxidation-reduction indicator. The addition of a chemical system having cholesterol ester hydrolase activity to the free cholesterol test composition provides an integral test composition for the determination of total cholesterol.
    Type: Grant
    Filed: March 1, 1973
    Date of Patent: January 29, 1980
    Assignee: Miles Laboratories, Inc.
    Inventor: Peter N. Tarbutton
  • Patent number: 4183786
    Abstract: A process for converting glycine to L-serine is effected by the use of an aqueous medium containing glycine and microbial cells of a mutant belonging to the genus Nocardia. The mutant is capable of converting glycine to L-serine and has no or lowered ability to decompose L-serine and/or a resistance to at least one metabolic antagonist selected from those of glycine, serine, methionine, glutamine, histidine, leucine, isoleucine, valine, purine, pyrimidine or folic acid. The L-serine is accumulated in the aqueous medium and is recovered therefrom.
    Type: Grant
    Filed: November 28, 1977
    Date of Patent: January 15, 1980
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Kiyoshi Nakayama, Kazumi Araki, Yoshitake Tanaka
  • Patent number: 4177106
    Abstract: Novel microbial transformation process to selectively convert steroids with or without 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to 3a.alpha.-H-4.alpha.-[3'-propanol]-7a.beta.-methylhexahydro-1,5-indaned ione hemiketal having the following structure: ##STR1## This compound can be used as an intermediate to make useful 19-nor steroids.
    Type: Grant
    Filed: February 21, 1978
    Date of Patent: December 4, 1979
    Assignee: The Upjohn Company
    Inventors: Thomas R. Pyke, Marion P. Salmond
  • Patent number: 4162940
    Abstract: A novel Antibiotic C-15003 is produced by cultivating a microorganism of the genus Nocardia.The Antibiotic C-15003 is useful as an antifungal agent or an antiprotozoan agent.
    Type: Grant
    Filed: June 29, 1977
    Date of Patent: July 31, 1979
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Eiji Higashide, Mitsuko Asai, Seiichi Tanida